Clinical Trial Update: Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer. [NA]

View source ↗

Summary

Clinical trial update describes evaluating Disitamab Vedotin with metronomic chemotherapy for advanced HER2-positive breast cancer; current trial status is unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Disitamab Vedotin (RC48) (disitamab vedotin)

Snippet

Sponsor: QIAO LI | Conditions: Breast Cancer | NA | Status: UNKNOWN